Gabriella Del Bene

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

Chiara Nicolazzo, Cristina Raimondi, M. Mancini et al. · Scientific Reports · 2016 · 267 citations · Full text

EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy

Arsela Prelaj, Sara Elena Rebuzzi, Pamela Pizzutilo et al. · Clinical Lung Cancer · 2020 · 80 citations

Prognostic Evaluation, Prognostic Biomarkers, Oncology +8

Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer

Eleonora Timperi, Ilenia Pacella, Valeria Schinzari et al. · OncoImmunology · 2016 · 79 citations · Full text

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial

Sandro Pignata, Giovanni Scambia, Clorinda Schettino et al. · The Lancet Oncology · 2023 · 46 citations

Medicine, Cancer Management, Mito End-3 +7

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

Giuseppe Procopio, Michele Prisciandaro, Roberto Iacovelli et al. · Clinical Genitourinary Cancer · 2018 · 39 citations

Urology, Real-world Data From, Metastatic Renal-cell Carcinoma +7